Top Suppliers:I want be here


1044511-01-4

1044511-01-4 structure
1044511-01-4 structure
  • Name: Benralizumab
  • Chemical Name: Benralizumab
  • CAS Number: 1044511-01-4
  • Molecular Formula: C6492H10060N1724O2028S42
  • Molecular Weight: 146054.0
  • Catalog: Signaling Pathways Immunology/Inflammation Interleukin Related
  • Create Date: 2020-01-24 00:12:51
  • Modify Date: 2024-01-05 17:17:39
  • Benralizumab (MEDI-563) is an interleukin-5 receptor α (IL-5Rα)-directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. Benralizumab can be used to treat severe eosinophilic asthma[1].

Name Benralizumab
Description Benralizumab (MEDI-563) is an interleukin-5 receptor α (IL-5Rα)-directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. Benralizumab can be used to treat severe eosinophilic asthma[1].
Related Catalog
Target

IL-5Rα[1]

References

[1]. Menzies-Gow A, et al. Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial. ERJ Open Res. 2019 Sep 25;5(3). pii: 00009-2019.

Molecular Formula C6492H10060N1724O2028S42
Molecular Weight 146054.0